Gregory Madison

Gregory Madison

Corporate Officer/Principal chez PROKIDNEY CORP.
59 ans
Health Technology
Health Services
Consumer Services

Profil

Gregory Paul Madison is currently Director at Phosphate Therapeutics Ltd. since 2021, Trustee at American Kidney Fund, Inc., and Chief Commercial Officer at ProKidney Corp.
starting in 2026.
Former roles include President, Chief Executive Officer & Director at Keryx Biopharmaceuticals, Inc. from 2015 to 2018; President, Chief Executive Officer & Director at Melt Pharmaceuticals, Inc.; Group Chief Executive Officer & Director at Shield Therapeutics Plc from 2021 to 2024; Director at Kidney Care Partners; Vice President & General Manager-Nephrology at Genzyme Corp.
from 2000 to 2012; and Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2013 to 2014.
Education includes undergraduate studies at the University of Massachusetts.

Postes actifs de Gregory Madison

SociétésPosteDébut
PROKIDNEY CORP. Corporate Officer/Principal 25/03/2026
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 18/06/2021

Anciens postes connus de Gregory Madison

SociétésPosteFin
SHIELD THERAPEUTICS PLC Directeur Général 24/07/2024
KERYX BIOPHARMACEUTICALS Directeur Général 30/04/2018
Directeur/Membre du Conseil 30/09/2014
AMAG PHARMACEUTICALS, INC. Corporate Officer/Principal 07/02/2014
Corporate Officer/Principal 01/01/2012
Voir l'expérience en détail de Gregory Madison

Formation de Gregory Madison

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Gregory Madison